Massachusetts Financial Services Co. MA Sells 1,090,484 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Massachusetts Financial Services Co. MA lessened its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 18.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,962,749 shares of the company’s stock after selling 1,090,484 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Definitive Healthcare were worth $20,397,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in DH. Principal Financial Group Inc. lifted its position in Definitive Healthcare by 9.7% during the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after acquiring an additional 3,874 shares during the last quarter. Rhumbline Advisers increased its position in shares of Definitive Healthcare by 5.2% during the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock worth $334,000 after purchasing an additional 4,034 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after purchasing an additional 6,794 shares during the last quarter. Point72 DIFC Ltd boosted its position in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after purchasing an additional 8,215 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in Definitive Healthcare by 44.6% during the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after buying an additional 8,387 shares during the last quarter. 98.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Stephens assumed coverage on Definitive Healthcare in a research note on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Barclays dropped their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research report on Monday, March 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, The Goldman Sachs Group dropped their price objective on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $5.35.

Definitive Healthcare Price Performance

Shares of DH opened at $2.51 on Monday. The business’s 50-day moving average is $3.91 and its two-hundred day moving average is $4.20. The company has a market capitalization of $283.41 million, a P/E ratio of -0.81, a P/E/G ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a fifty-two week low of $2.32 and a fifty-two week high of $8.02. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The company had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Research analysts predict that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.